-
1
-
-
0037213011
-
-
Pottorf R.S., Chadha N.K., Katkevies M., Ozola V., Suna E., Ghane H., Regberg T., and Player M.R. Tetrahedron Lett. 44 (2003) 175
-
(2003)
Tetrahedron Lett.
, vol.44
, pp. 175
-
-
Pottorf, R.S.1
Chadha, N.K.2
Katkevies, M.3
Ozola, V.4
Suna, E.5
Ghane, H.6
Regberg, T.7
Player, M.R.8
-
5
-
-
33750501997
-
-
Metwally K.A., Abdel-Aziz L.M., Lashine E.M., Husseiny M.I., and Badawy R. Bioorg. Med. Chem. 14 24 (2006) 8675
-
(2006)
Bioorg. Med. Chem.
, vol.14
, Issue.24
, pp. 8675
-
-
Metwally, K.A.1
Abdel-Aziz, L.M.2
Lashine, E.M.3
Husseiny, M.I.4
Badawy, R.5
-
9
-
-
0031470115
-
-
Oren I., Temiz O., Yalçi{dotless}n I., Sener E., Aki{dotless}n A., and Uçartürk N. Arzneim.-Forsch./Drug. Res. 47 12 (1997) 1393
-
(1997)
Arzneim.-Forsch./Drug. Res.
, vol.47
, Issue.12
, pp. 1393
-
-
Oren, I.1
Temiz, O.2
Yalçin, I.3
Sener, E.4
Akin, A.5
Uçartürk, N.6
-
10
-
-
0037598935
-
-
Oren I., Temiz O., Yalçi{dotless}n I., Sener E., and Altanlar N. Eur. J. Pharm. Sci. 7 (1998) 153
-
(1998)
Eur. J. Pharm. Sci.
, vol.7
, pp. 153
-
-
Oren, I.1
Temiz, O.2
Yalçin, I.3
Sener, E.4
Altanlar, N.5
-
12
-
-
17844374872
-
-
Temiz-Arpaci{dotless} O., Özdemir A., Yalçi{dotless}n I., Yi{dotless}ldi{dotless}z I., Aki{dotless}-Şener E., and Altanlar N. Arch. Pharm. 338 2-3 (2005) 105
-
(2005)
Arch. Pharm.
, vol.338
, Issue.2-3
, pp. 105
-
-
Temiz-Arpaci, O.1
Özdemir, A.2
Yalçin, I.3
Yildiz, I.4
Aki-Şener, E.5
Altanlar, N.6
-
14
-
-
0038745928
-
-
Akbay A., Oren I., Temiz-Arpaci{dotless} O., Aki{dotless}-Şener E., and Yalçi{dotless}n I. Arzneim. Forsch. 54 3 (2003) 266
-
(2003)
Arzneim. Forsch.
, vol.54
, Issue.3
, pp. 266
-
-
Akbay, A.1
Oren, I.2
Temiz-Arpaci, O.3
Aki-Şener, E.4
Yalçin, I.5
-
15
-
-
1842426000
-
-
Pi{dotless}nar A., Yurdakul P., Yi{dotless}ldi{dotless}z-Ören I., Temiz-Arpaci{dotless} O., Acan N.L., Aki{dotless}-Şener E., and Yalçi{dotless}n I. Biochem. Biophys. Res. Commun. 317 2 (2004) 670
-
(2004)
Biochem. Biophys. Res. Commun.
, vol.317
, Issue.2
, pp. 670
-
-
Pinar, A.1
Yurdakul, P.2
Yildiz-Ören, I.3
Temiz-Arpaci, O.4
Acan, N.L.5
Aki-Şener, E.6
Yalçin, I.7
-
17
-
-
27744570901
-
-
Varga A., Aki{dotless}-Şener E., Yalçi{dotless}n I., Temiz-Arpaci{dotless} O., Tekiner-Gülbaş B., Cherepnev G., and Molnar J. In Vivo 19 6 (2005) 1087
-
(2005)
In Vivo
, vol.19
, Issue.6
, pp. 1087
-
-
Varga, A.1
Aki-Şener, E.2
Yalçin, I.3
Temiz-Arpaci, O.4
Tekiner-Gülbaş, B.5
Cherepnev, G.6
Molnar, J.7
-
18
-
-
0038652733
-
-
Şener E., Özden S., Yalçi{dotless}n I., Özden T., Aki{dotless}n A., and Yi{dotless}ldi{dotless}z S. FABAD J. Pharm. Sci. 11 (1986) 190
-
(1986)
FABAD J. Pharm. Sci.
, vol.11
, pp. 190
-
-
Şener, E.1
Özden, S.2
Yalçin, I.3
Özden, T.4
Akin, A.5
Yildiz, S.6
-
19
-
-
34249300595
-
-
Yalçi{dotless}n I., Şener E., Özden S., Özden T., Aki{dotless}n A., and Yi{dotless}ldi{dotless}z S. FABAD J. Pharm. Sci. 11 (1986) 257
-
(1986)
FABAD J. Pharm. Sci.
, vol.11
, pp. 257
-
-
Yalçin, I.1
Şener, E.2
Özden, S.3
Özden, T.4
Akin, A.5
Yildiz, S.6
-
20
-
-
45849083813
-
-
Özden T., Özden S., Şener E., Yalçi{dotless}n I., Aki{dotless}n A., and Yi{dotless}ldi{dotless}z S. FABAD J. Pharm. Sci. 12 (1987) 39
-
(1987)
FABAD J. Pharm. Sci.
, vol.12
, pp. 39
-
-
Özden, T.1
Özden, S.2
Şener, E.3
Yalçin, I.4
Akin, A.5
Yildiz, S.6
-
21
-
-
0023503040
-
-
Şener E., Yalçi{dotless}n I., Özden S., and Özden T. Doǧa Bil. Der. 11 3 (1987) 391
-
(1987)
Doǧa Bil. Der.
, vol.11
, Issue.3
, pp. 391
-
-
Şener, E.1
Yalçin, I.2
Özden, S.3
Özden, T.4
-
22
-
-
0025202508
-
-
Yalçi{dotless}n I., Sener E., Özden T., Özden S., and Aki{dotless}n A. Eur. J. Med. Chem. 25 (1990) 705
-
(1990)
Eur. J. Med. Chem.
, vol.25
, pp. 705
-
-
Yalçin, I.1
Sener, E.2
Özden, T.3
Özden, S.4
Akin, A.5
-
23
-
-
45849106067
-
-
Yalçi{dotless}n I., Oren I., Şener E., Aki{dotless}n A., and Uçartürk N. Eur. J. Med. Chem. 27 (1992) 568
-
(1992)
Eur. J. Med. Chem.
, vol.27
, pp. 568
-
-
Yalçin, I.1
Oren, I.2
Şener, E.3
Akin, A.4
Uçartürk, N.5
-
24
-
-
33745627640
-
-
Approved Standard, M2-A9, Clinical and Laboratory Standards Institute, 940 West Valley Road, Wayne, Pennsylvania, USA
-
Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS). Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard, M2-A9 (2006), Clinical and Laboratory Standards Institute, 940 West Valley Road, Wayne, Pennsylvania, USA
-
(2006)
Performance Standards for Antimicrobial Disk Susceptibility Tests
-
-
Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS)1
-
25
-
-
33646696219
-
-
16th Informational Supplement. CLSI M100-S16, Clinical and Laboratory Standards Institute, 940 West Valley Road, Wayne, Pennsylvania, USA
-
Clinical and Laboratory Laboratory Standards Institute (CLSI) (formerly NCCLS). Performance Standards for Antimicrobial Susceptibility Testing. 16th Informational Supplement. CLSI M100-S16 (2006), Clinical and Laboratory Standards Institute, 940 West Valley Road, Wayne, Pennsylvania, USA
-
(2006)
Performance Standards for Antimicrobial Susceptibility Testing
-
-
Clinical and Laboratory Laboratory Standards Institute (CLSI) (formerly NCCLS)1
-
26
-
-
0037667327
-
-
Approved standard, M27-A, Clinical and Laboratory Standards Institute, 940 West Valley Road, Wayne, Pennsylvania, USA
-
Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS). Reference Method for Broth Dilution Antifungal Susceptibility Testing Yeast. Approved standard, M27-A (2006), Clinical and Laboratory Standards Institute, 940 West Valley Road, Wayne, Pennsylvania, USA
-
(2006)
Reference Method for Broth Dilution Antifungal Susceptibility Testing Yeast
-
-
Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS)1
|